カテゴリー： 世界, 医療/バイオ, Grand View Research

調剤薬局の世界市場2023-2030：市場規模、シェア、動向分析

【英語タイトル】Compounding Pharmacies Market Size, Share & Trends Analysis Report By Therapeutic Area (Specialty Drugs, Dermatology), By Age Cohort (Pediatric, Adult), By Compounding Type (PIA, PDA), By Sterility, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23OCT059）・商品コード：GRV23OCT059
・発行会社（調査会社）：Grand View Research
・発行日：2023年8月
・ページ数：168
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

調剤薬局市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の調剤薬局市場規模は2030年までに186億米ドルに達する見込みです。予測期間中の年平均成長率は5.11%と予測されています。同市場の成長は、服薬アドヒアランスの重要性の高まりと、政府の支援政策の増加に起因しています。例えば、2022年11月、米国食品医薬品局は、調合監視、および調合品質法（CQA）の実施を支援する取り組みについて議論する第11回政府間会議を実施しました。さらに、個別化医療に対する需要の高まりが市場の成長を後押ししています。調剤薬局は、個々の患者のユニークなニーズに基づいてカスタマイズされた薬を作成することを専門としています。

小児や高齢者は、年齢による特有のニーズから、独自の強さの薬や別の剤形の薬を必要とすることがよくあります。調剤薬局では、投与しやすいように液状懸濁液を処方したり、体重に応じて投与量を調整するなど、これらの集団の特定の要件を満たすように薬を調整することができます。COVID-19のパンデミックは、初期段階では市場に若干の影響を与えました。慢性疾患を患う患者が各国の政府による封鎖や一部の国の薬局の閉鎖により薬を入手できなくなったため、市場は2021年の初めに回復しました。いくつかの調剤薬局は、消費者がオンラインで調剤処方箋を預け、玄関先で薬を受け取ることができる簡単で安全な方法を提供し始め、その結果、パンデミック時の需要が増加しました。

調剤薬局市場レポートハイライト

- 治療分野別では、市販の疼痛管理薬の副作用に対処するためのテーラーメイドのアプローチにより、疼痛管理分野が2022年に最大の売上シェアを獲得しました。

- 年齢層別では、特定の投与強度、特定の成分に対するアレルギーや過敏症、代替剤形への嗜好などの要因から、成人セグメントが2022年に最大の収益シェアを占めました。

- 配合タイプ別では、医薬品成分変更（PIA）セグメントが市場を支配しています。これは、特別なニーズを持つ患者からカスタマイズされた医薬品に対する需要が高いためと考えられます。

- 無菌製剤セグメントは、小児および老人患者のさまざまな剤形の静脈内無菌製剤に対する高い需要に起因して、2022年に最大の収益シェアで市場を支配しました。

- 北米地域は、調剤サービスを提供する薬局が多数存在し、FDAなどの当局からの支援が増加しているため、2022年に最大の収益シェアを占めました。

第1章. 方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 調剤薬局市場：治療領域別予測・動向分析
第5章. 調剤薬局市場：年齢別コーホート別予測・動向分析
第6章. 調剤薬局市場：配合種類別予測・動向分析
第7章. 調剤薬局市場：無菌性別予測・動向分析
第8章. 調剤薬局市場：地域別予測・動向分析
第9章. 競争状況
第10章. 提言/主要市場インサイト

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.3.1. Information procurement
1.3.2. Purchased Database
1.3.3. GVR’s Internal Database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.3.6. Details of Primary Research
1.4. Information or Data Analysis
1.4.1. Data Analysis Models
1.5. 1.5 Market Formulation & Validation
1.5.1. Volume Price Analysis
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Research Objectives
1.8.1. Objective – 1
1.8.2. Objective – 2
1.8.3. Objective – 3
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Dynamics
3.1.1. Market Driver Analysis
3.1.1.1. Increasing supportive government policies
3.1.1.2. Increasing demand for personalized medications
3.1.1.3. Growing importance of pharmaceutical compounding in promoting medication adherence
3.1.2. Market Restraint Analysis
3.1.2.1. Risk of Chemical Contamination
3.1.2.2. Chances of human errors or medication errors
3.2. Industry Analysis Tools
3.2.1. Porter’s Five Forces Analysis
3.2.2. PESTLE Analysis
3.3. COVID-19 Impact Analysis
Chapter 4. Compounding Pharmacies Market: Therapeutic Area Estimates & Trend Analysis
4.1. Segment Definitions
4.2. Compounding Pharmacies Market: Segment Dashboard
4.3. Compounding Pharmacies Market: Therapeutic Area Movement & Market Share Analysis
4.4. Hormone Replacement Therapy
4.4.1. Hormone Replacement Therapy Market, 2018 – 2030 (USD Million)
4.5. Pain Management
4.5.1. Pain Management Market, 2018 – 2030 (USD Million)
4.6. Dermatology
4.6.1. Dermatology Market, 2018 – 2030 (USD Million)
4.7. Specialty Drugs
4.7.1. Specialty Drugs Market, 2018 – 2030 (USD Million)
4.8. Nutritional Supplements
4.8.1. Nutritional Supplements Market, 2018 – 2030 (USD Million)
4.9. Others
4.9.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. Compounding Pharmacies Market: Age Cohort Estimates & Trend Analysis
5.1. Segment Definitions
5.2. Compounding Pharmacies Market: Segment Dashboard
5.3. Compounding Pharmacies Market: Age Cohort Movement & Market Share Analysis
5.4. Pediatric
5.4.1. Pediatric Market, 2018 – 2030 (USD Million)
5.5. Adult
5.5.1. Adult Market, 2018 – 2030 (USD Million)
5.6. Geriatric
5.6.1. Geriatric Market, 2018 – 2030 (USD Million)
Chapter 6. Compounding Pharmacies Market: Compounding Type Estimates & Trend Analysis
6.1. Segment Definitions
6.2. Compounding Pharmacies Market: Segment Dashboard
6.3. Compounding Pharmacies Market: Compounding type Movement & Market share Analysis
6.4. Pharmaceutical Ingredient Alteration (PIA)
6.4.1. Pharmaceutical Ingredient Alteration (PIA) Market, 2018 – 2030 (USD Million)
6.5. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
6.5.1. Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market, 2018 – 2030 (USD Million)
6.6. Pharmaceutical Dosage Alteration (PDA)
6.6.1. Pharmaceutical Dosage Alteration (PDA) Market, 2018 – 2030 (USD Million)
6.7. Others
6.7.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. Compounding Pharmacies Market: Sterility Estimates & Trend Analysis
7.1. Segment Definitions
7.2. Compounding Pharmacies Market: Segment Dashboard
7.3. Compounding Pharmacies Market: Sterility Movement & Market Share Analysis
7.4. Sterility
7.4.1. Sterility Market, 2018 – 2030 (USD Million)
7.5. Non-Sterility
7.5.1. Non-Sterility Market, 2018 – 2030 (USD Million)
Chapter 8. Compounding Pharmacies Market: Regional Estimates & Trend Analysis
8.1. Compounding Pharmacies Market: Regional Movement Analysis, 2022 & 2030
8.2. North America
8.2.1. North America Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Regulatory Scenario
8.2.2.3. Competitive Scenario
8.2.2.4. U.S. Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Regulatory Scenario
8.2.3.3. Competitive Scenario
8.2.3.4. Canada Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.3. Europe
8.3.1. Europe Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Regulatory Scenario
8.3.2.3. Competitive Scenario
8.3.2.4. UK Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Regulatory Scenario
8.3.3.3. Competitive Scenario
8.3.3.4. Germany Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Regulatory Scenario
8.3.4.3. Competitive Scenario
8.3.4.4. France Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Regulatory Scenario
8.3.5.3. Competitive Scenario
8.3.5.4. Italy Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Regulatory Scenario
8.3.6.3. Competitive Scenario
8.3.6.4. Spain Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Regulatory Scenario
8.3.7.3. Competitive Scenario
8.3.7.4. Denmark Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Regulatory Scenario
8.3.8.3. Competitive Scenario
8.3.8.4. Sweden Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Regulatory Scenario
8.3.9.3. Competitive Scenario
8.3.9.4. Norway Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Regulatory Scenario
8.4.2.3. Competitive Scenario
8.4.2.4. Japan Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Regulatory Scenario
8.4.3.3. Competitive Scenario
8.4.3.4. China Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Regulatory Scenario
8.4.4.3. Competitive Scenario
8.4.4.4. India Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Regulatory Scenario
8.4.5.3. Competitive Scenario
8.4.5.4. Australia Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Regulatory Scenario
8.4.6.3. Competitive Scenario
8.4.6.4. Thailand Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Regulatory Scenario
8.4.7.3. Competitive Scenario
8.4.7.4. South Korea Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Regulatory Scenario
8.5.2.3. Competitive Scenario
8.5.2.4. Brazil Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Regulatory Scenario
8.5.3.3. Competitive Scenario
8.5.3.4. Mexico Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Regulatory Scenario
8.5.4.3. Competitive Scenario
8.5.4.4. Argentina Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.6. Middle East & Africa
8.6.1. Middle East & Africa Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Regulatory Scenario
8.6.2.3. Competitive Scenario
8.6.2.4. South Africa Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Regulatory Scenario
8.6.3.3. Competitive Scenario
8.6.3.4. Saudi Arabia Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Regulatory Scenario
8.6.4.3. Competitive Scenario
8.6.4.4. UAE Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Regulatory Scenario
8.6.5.3. Competitive Scenario
8.6.5.4. Kuwait Compounding Pharmacies Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Profiles
9.1.1. Walgreens Co.
9.1.1.1. Overview
9.1.1.2. Financial Performance
9.1.1.3. Service Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. JL Diekman and AQ Touchard (Fresh Therapeutics Compounding Pharmacy)
9.1.2.1. Overview
9.1.2.2. Financial Performance
9.1.2.3. Service Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Fagron.
9.1.3.1. Overview
9.1.3.2. Financial Performance
9.1.3.3. Service Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. Albertsons Companies
9.1.4.1. Overview
9.1.4.2. Financial Performance
9.1.4.3. Service Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. The London Specialist Pharmacy Ltd (Specialist Pharmacy)
9.1.5.1. Overview
9.1.5.2. Financial Performance
9.1.5.3. Service Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. Galenic Laboratories Limited (Roseway Labs)
9.1.6.1. Overview
9.1.6.2. Financial Performance
9.1.6.3. Service Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. Aurora Compounding
9.1.7.1. Overview
9.1.7.2. Financial Performance
9.1.7.3. Service Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. MEDS Pharmacy
9.1.8.1. Overview
9.1.8.2. Financial Performance
9.1.8.3. Service Benchmarking
9.1.8.4. Strategic Initiatives
9.1.9. Apollo Clinical Pharmacy
9.1.9.1. Overview
9.1.9.2. Financial Performance
9.1.9.3. Service Benchmarking
9.1.9.4. Strategic Initiatives
9.1.10. Formul8
9.1.10.1. Overview
9.1.10.2. Financial Performance
9.1.10.3. Service Benchmarking
9.1.10.4. Strategic Initiatives
9.1.11. Fusion Apothecary
9.1.11.1. Overview
9.1.11.2. Financial Performance
9.1.11.3. Service Benchmarking
9.1.11.4. Strategic Initiatives
9.2. Company Categorization
9.3. Company Market Position Analysis
9.4. Strategy Mapping
Chapter 10. Recommendations/Key Market Insights

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 4 Global compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 5 Global compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 6 Global compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 7 Global compounding pharmacies market, by region, 2018 - 2030 (USD Million)
Table 8 North America compounding pharmacies market, by country, 2018 - 2030 (USD Million)
Table 9 North America compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 10 North America compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 11 North America compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 12 North America compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 13 U.S. compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 14 U.S. compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 15 U.S. compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 16 U.S. compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 17 Canada compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 18 Canada compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 19 Canada compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 20 Canada compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 21 Europe compounding pharmacies market, by country, 2018 - 2030 (USD Million)
Table 22 Europe compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 23 Europe compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 24 Europe compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 25 Europe compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 26 UK compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 27 UK compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 28 UK compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 29 UK compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 30 Germany compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 31 Germany compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 32 Germany compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 33 Germany compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 34 France compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 35 France compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 36 France compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 37 France compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 38 Italy compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 39 Italy compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 40 Italy compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 41 Italy compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 42 Spain compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 43 Spain compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 44 Spain compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 45 Spain compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 46 Denmark compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 47 Denmark compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 48 Denmark compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 49 Denmark compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 50 Sweden compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 51 Sweden compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 52 Sweden compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 53 Sweden compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 54 Norway compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 55 Norway compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 56 Norway compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 57 Norway compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 58 Asia Pacific compounding pharmacies market, by country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 60 Asia Pacific compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 61 Asia Pacific compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 62 Asia Pacific compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 63 Japan compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 64 Japan compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 65 Japan compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 66 Japan compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 67 India compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 68 India compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 69 India compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 70 India compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 71 China compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 72 China compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 73 China compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 74 China compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 75 Australia compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 76 Australia compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 77 Australia compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 78 Australia compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 79 Thailand compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 80 Thailand compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 81 Thailand compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 82 Thailand compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 83 South Korea compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 84 South Korea compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 85 South Korea compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 86 South Korea compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 87 Latin America compounding pharmacies market, by country, 2018 - 2030 (USD Million)
Table 88 Latin America compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 89 Latin America compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 90 Latin America compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 91 Latin America compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 92 Brazil compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 93 Brazil compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 94 Brazil compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 95 Brazil compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 96 Mexico compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 97 Mexico compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 98 Mexico compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 99 Mexico compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 100 Argentina compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 101 Argentina compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 102 Argentina compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 103 Argentina compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa compounding pharmacies market, by country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 109 South Africa compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 110 South Africa compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 111 South Africa compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 112 South Africa compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 117 UAE compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 118 UAE compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 119 UAE compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 120 UAE compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 121 Kuwait compounding pharmacies market, by therapeutic area, 2018 - 2030 (USD Million)
Table 122 Kuwait compounding pharmacies market, by age cohort, 2018 - 2030 (USD Million)
Table 123 Kuwait compounding pharmacies market, by compounding type, 2018 - 2030 (USD Million)
Table 124 Kuwait compounding pharmacies market, by sterility, 2018 - 2030 (USD Million)
Table 125 Participant's overview
Table 126 Financial performance
Table 127 Key companies undergoing expansions
Table 128 Key Companies Undertaking Acquisitions
Table 129 Key companies undergoing partnership & collaborations
Table 130 Key companies launching new products
Table 131 Key companies undergoing other strategies

★調査レポート[調剤薬局の世界市場2023-2030：市場規模、シェア、動向分析] (コード：GRV23OCT059)販売に関する免責事項を必ずご確認ください。
★調査レポート[調剤薬局の世界市場2023-2030：市場規模、シェア、動向分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 調剤薬局の世界市場2023-2030：市場規模、シェア、動向分析
  • 関節内補充療法の世界市場2023-2030：市場規模、シェア、動向分析
  • 関節内補充療法の世界市場2023-2030：市場規模、シェア、動向分析
  • 医療用繊維の世界市場2023-2030：市場規模、シェア、動向分析
  • 医療用繊維の世界市場2023-2030：市場規模、シェア、動向分析
  • 小児在宅医療の世界市場2023-2030：市場規模、シェア、動向分析
  • 小児在宅医療の世界市場2023-2030：市場規模、シェア、動向分析
  • DNA診断の世界市場2023-2030：市場規模、シェア、動向分析
  • DNA診断の世界市場2023-2030：市場規模、シェア、動向分析
  • 次世代がん診断の世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆